Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Räth

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Der Radiologe|March 1, 1983
[Sonographic diagnosis in primary cancer of the liver]U Räth, P J Johnson, R Williams
American Journal of Clinical Oncology|October 1, 1989
Intrahepatic 5-FU retreatment of liver metastases of colorectal cancer that were progressive under previous systemic chemotherapyP Hohenberger, P Schlag, R Herrmann, et al.
Der Internist|November 1, 1992
[5-HT3 antagonists in therapy of cystostatic drug-induced vomiting]N Marschner, J H Beyer, U Räth, et al.
Klinische Wochenschrift|January 15, 1988
Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995B Wiedenmann, U Räth, R Rädsch, et al.
Lancet (London, England)|November 10, 2000
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study GroupC Bonithon-Kopp, O Kronborg, A Giacosa, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1993
Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogsU Dörr, K Wurm, E Höring, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Treatment of the carcinoid syndrome with a depot formulation of the somatostatin analogue lanreotideH Scherübl, B Wiedenmann, E O Riecken, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 1, 1989
[Quantitative studies on the influence of connective tissue and fatty structures on the ultrasonic image of the liver]U Haberkorn, I Zuna, H Zerban, et al.
Digestion|September 4, 1999
Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumorsS Faiss, U Räth, U Mansmann, et al.
Ultrasonic Imaging|July 1, 1990
Echographic tissue characterization in diffuse parenchymal liver disease: correlation of image structure with histologyU Haberkorn, I Zuna, A Lorenz, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Der Radiologe|March 1, 1983
[Sonographic diagnosis in primary cancer of the liver]U Räth, P J Johnson, R Williams
American Journal of Clinical Oncology|October 1, 1989
Intrahepatic 5-FU retreatment of liver metastases of colorectal cancer that were progressive under previous systemic chemotherapyP Hohenberger, P Schlag, R Herrmann, et al.
Der Internist|November 1, 1992
[5-HT3 antagonists in therapy of cystostatic drug-induced vomiting]N Marschner, J H Beyer, U Räth, et al.
Klinische Wochenschrift|January 15, 1988
Tumor regression of an ileal carcinoid under the treatment with the somatostatin analogue SMS 201-995B Wiedenmann, U Räth, R Rädsch, et al.
Lancet (London, England)|November 10, 2000
Calcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomised intervention trial. European Cancer Prevention Organisation Study GroupC Bonithon-Kopp, O Kronborg, A Giacosa, et al.
Hormone and Metabolic Research. Supplement Series|January 1, 1993
Diagnostic reliability of somatostatin receptor scintigraphy during continuous treatment with different somatostatin analogsU Dörr, K Wurm, E Höring, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Treatment of the carcinoid syndrome with a depot formulation of the somatostatin analogue lanreotideH Scherübl, B Wiedenmann, E O Riecken, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|October 1, 1989
[Quantitative studies on the influence of connective tissue and fatty structures on the ultrasonic image of the liver]U Haberkorn, I Zuna, H Zerban, et al.
Digestion|September 4, 1999
Ultra-high-dose lanreotide treatment in patients with metastatic neuroendocrine gastroenteropancreatic tumorsS Faiss, U Räth, U Mansmann, et al.
Ultrasonic Imaging|July 1, 1990
Echographic tissue characterization in diffuse parenchymal liver disease: correlation of image structure with histologyU Haberkorn, I Zuna, A Lorenz, et al.
Pageof 4